Global and China Kidney Cancer Drug Market Research Report Forecast 2017-2021

May 2017 | 114 pages | ID: G7373E2AD67EN
S&P Consulting

Abstracts

The Global and China Kidney Cancer Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Kidney Cancer Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Kidney Cancer Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global and China Kidney Cancer Drug Market: Regional Segment Analysis
Global
China

The Major players reported in the market include:
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics

Global and China Kidney Cancer Drug Market: Product Segment Analysis
Type 1
Type 2
Type 3

Global and China Kidney Cancer Drug Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 KIDNEY CANCER DRUG MARKET OVERVIEW

1.1 Kidney Cancer Drug Definition
1.2 Kidney Cancer Drug Classification and Application
1.3 Kidney Cancer Drug Industry Chain
1.4 Kidney Cancer Drug Industry Overview

CHAPTER 2 GLOBAL AND CHINA ECONOMIC IMPACT ON KIDNEY CANCER DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
2.2 China Macroeconomic Environment Analysis

CHAPTER 3 GLOBAL KIDNEY CANCER DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

3.1 Global Kidney Cancer Drug Market Competition by Manufacturers
  3.1.1 Global Kidney Cancer Drug Production and Market Share of Key Manufacturers (2012-2017)
  3.1.2 Global Kidney Cancer Drug Revenue and Share by Manufacturers (2012-2017)
3.2 Global Kidney Cancer Drug Production and Revenue by Type
  3.3.1 Global Kidney Cancer Drug Production and Market Share by Type (2012-2017)
  3.3.2 Global Kidney Cancer Drug Revenue and Market Share by Type (2012-2017)
3.3 Global Kidney Cancer Drug Production and Revenue by Application

CHAPTER 4 CHINA KIDNEY CANCER DRUG MARKET ANALYSIS

4.1 China Kidney Cancer Drug Production and Revenue (2012-2014)
  4.1.1 China Kidney Cancer Drug Production and Growth Rate (2012-2014)
  4.1.2 China Kidney Cancer Drug Revenue and Growth Rate (2012-2014)
  4.1.3 China Kidney Cancer Drug Sales Price Trend (2012-2014)
4.2 China Kidney Cancer Drug Production and Market Share by Manufacturers
4.3 China Kidney Cancer Drug Production and Market Share by Type
4.4 China Kidney Cancer Drug Production and Market Share by Application

CHAPTER 5 GLOBAL KIDNEY CANCER DRUG MANUFACTURERS ANALYSIS

5.1 Bayer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Product Type, Application and Specification
  5.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.1.4 Business Overview
5.2 F. Hoffmann-La Roche
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 Product Type, Application and Specification
  5.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.2.4 Business Overview
5.3 GlaxoSmithKline
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 Product Type, Application and Specification
  5.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.3.4 Business Overview
5.4 Novartis
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 Product Type, Application and Specification
  5.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.4.4 Business Overview
5.5 Pfizer
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 Product Type, Application and Specification
  5.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.5.4 Business Overview
5.6 Abbott Laboratories
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 Product Type, Application and Specification
  5.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.6.4 Business Overview
5.7 Active Biotech
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 Product Type, Application and Specification
  5.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.7.4 Business Overview
5.8 Amgen
  5.8.1 Company Basic Information, Manufacturing Base and Competitors
  5.8.2 Product Type, Application and Specification
  5.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.8.4 Business Overview
5.9 Argos Therapeutics
  5.9.1 Company Basic Information, Manufacturing Base and Competitors
  5.9.2 Product Type, Application and Specification
  5.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.9.4 Business Overview

CHAPTER 6 KIDNEY CANCER DRUG MANUFACTURING COST ANALYSIS

6.1 Kidney Cancer Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Kidney Cancer Drug

CHAPTER 7 MARKET EFFECT FACTORS ANALYSIS

7.1 Technology Progress/Risk
  7.1.1 Substitutes Threat
  7.1.2 Technology Progress in Related Industry
7.2 Consumer Needs/Customer Preference Change
7.3 Economic/Political Environmental Change

CHAPTER 8 GLOBAL KIDNEY CANCER DRUG MARKET FORECAST (2017-2021)

8.1 Global Kidney Cancer Drug Production, Revenue Forecast (2017-2021)
8.2 Global Kidney Cancer Drug Production Forecast by Type (2017-2021)
8.3 Global Kidney Cancer Drug Consumption Forecast by Application (2017-2021)
8.4 China Kidney Cancer Drug Production, Consumption Forecast by Regions (2017-2021)
8.5 Kidney Cancer Drug Price Forecast (2017-2021)

CHAPTER 9 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Kidney Cancer Drug
Figure Global Production Market Share of Kidney Cancer Drug by Type in 2015
Table Kidney Cancer Drug Consumption Market Share by Application in 2015
Table Global Kidney Cancer Drug Capacity of Key Manufacturers (2015 and 2016)
Table Global Kidney Cancer Drug Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Kidney Cancer Drug Capacity of Key Manufacturers in 2015
Figure Global Kidney Cancer Drug Capacity of Key Manufacturers in 2016
Table Global Kidney Cancer Drug Production of Key Manufacturers (2015 and 2016)
Table Global Kidney Cancer Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Kidney Cancer Drug Production Share by Manufacturers
Figure 2016 Kidney Cancer Drug Production Share by Manufacturers
Table Global Kidney Cancer Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Kidney Cancer Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Kidney Cancer Drug Revenue Share by Manufacturers
Table 2016 Global Kidney Cancer Drug Revenue Share by Manufacturers
Table Global Market Kidney Cancer Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Kidney Cancer Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Kidney Cancer Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Kidney Cancer Drug Product Type
Figure Kidney Cancer Drug Market Share of Top 3 Manufacturers
Figure Kidney Cancer Drug Market Share of Top 5 Manufacturers
Table Global Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table China Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Kidney Cancer Drug Production by Type (2012-2017)
Table Global Kidney Cancer Drug Production Share by Type (2012-2017)
Figure Production Market Share of Kidney Cancer Drug by Type (2012-2017)
Figure 2015 Production Market Share of Kidney Cancer Drug by Type
Table Global Kidney Cancer Drug Revenue by Type (2012-2017)
Table Global Kidney Cancer Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Kidney Cancer Drug by Type (2012-2017)
Figure 2015 Revenue Market Share of Kidney Cancer Drug by Type
Table Global Kidney Cancer Drug Price by Type (2012-2017)
Figure Global Kidney Cancer Drug Production Growth by Type (2012-2017)
Table Global Kidney Cancer Drug Consumption by Application (2012-2017)
Table Global Kidney Cancer Drug Consumption Market Share by Application (2012-2017)
Figure Global Kidney Cancer Drug Consumption Market Share by Application in 2015
Table Global Kidney Cancer Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Kidney Cancer Drug Consumption Growth Rate by Application (2012-2017)
Figure China Kidney Cancer Drug Production and Growth Rate (2012-2017)
Figure China Kidney Cancer Drug Revenue and Growth Rate (2012-2017)
Figure China Kidney Cancer Drug Production Price Trend (2012-2017)
Table China Kidney Cancer Drug Production by Manufacturers (2012-2017)
Table China Kidney Cancer Drug Market Share by Manufacturers (2012-2017)
Table China Kidney Cancer Drug Production by Type (2012-2017)
Table China Kidney Cancer Drug Market Share by Type (2012-2017)
Table China Kidney Cancer Drug Production by Application (2012-2017)
Table China Kidney Cancer Drug Market Share by Application (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Kidney Cancer Drug Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffmann-La Roche Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Kidney Cancer Drug Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Kidney Cancer Drug Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Kidney Cancer Drug Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Kidney Cancer Drug Market Share (2012-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Kidney Cancer Drug Market Share (2012-2017)
Table Active Biotech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Active Biotech Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Active Biotech Kidney Cancer Drug Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Kidney Cancer Drug Market Share (2012-2017)
Table Argos Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Argos Therapeutics Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Argos Therapeutics Kidney Cancer Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kidney Cancer Drug
Figure Manufacturing Process Analysis of Kidney Cancer Drug
Figure Kidney Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Kidney Cancer Drug
Table Distributors/Traders List
Figure Global Kidney Cancer Drug Production and Growth Rate Forecast (2017-2021)
Figure Global Kidney Cancer Drug Revenue and Growth Rate Forecast (2017-2021)
Table Global Kidney Cancer Drug Production Forecast by Type (2017-2021)
Table Global Kidney Cancer Drug Consumption Forecast by Application (2017-2021)
Table China Kidney Cancer Drug Production and Consumption Forecast by Regions (2017-2021)

COMPANIES MENTIONED

Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics
ArQule
AVEO Pharmaceuticals
Bionomics
Bristol-Myers Squibb
Cerulean Pharma
Exelixis
Genentech
immatics biotechnologies
Immunicum
Ono Pharmaceutical
Onyx Therapeutics
Oxford BioMedica
Prometheus Laboratories
Seattle Genetics
Taiwan Liposome
TRACON Pharmaceuticals
Wilex